Litcius/Paper detail

Fasting and post-oral-glucose-load levels of methylglyoxal are associated with microvascular, but not macrovascular, disease in individuals with and without (pre)diabetes: The Maastricht Study

Nordin M.J. Hanssen, Jean L.J.M. Scheijen, Alfons J.H.M. Houben, Marjo Van de Waarenburg, Tos T. J. M. Berendschot, Carroll A.B. Webers, Koen D. Reesink, Marleen M. J. van Greevenbroek, Carla Kallen, Nicolaas C. Schaper, Miranda T. Schram, Ronald M.A. Henry, Coen D.A. Stehouwer, Casper G. Schalkwijk

2020Diabetes & Metabolism27 citationsDOIOpen Access PDF

Topics & Concepts

MedicineInternal medicineAlbuminuriaDiabetes mellitusPrediabetesEndocrinologyMacrovascular diseaseType 2 diabetesKidney diseaseBlood pressureRenal functionDiabetic retinopathyImpaired glucose toleranceAdvanced Glycation End Products researchFatty Acid Research and HealthDiabetes Treatment and Management
Fasting and post-oral-glucose-load levels of methylglyoxal are associated with microvascular, but not macrovascular, disease in individuals with and without (pre)diabetes: The Maastricht Study | Litcius